8-KShareholder Matters

DEXCOM INC 8-K Report, Shareholder Vote Results (Jun 1, 2011)

Filed June 1, 2011For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed this Form 8-K on June 1, 2011, reporting on its Annual Meeting of Shareholders held on May 25, 2011. The primary purpose of the filing was to disclose the voting results on several key matters put before the shareholders. These included the election of directors, ratification of the independent auditor, and advisory votes on executive compensation and the frequency of future advisory votes on executive compensation. The results indicate strong shareholder support for the company's proposed slate of directors and its choice of auditors. Of particular note for investors is the outcome of the advisory vote on executive compensation and the frequency of such votes. Shareholders approved the executive compensation in an advisory capacity and, importantly, favored holding this advisory vote annually. This demonstrates a shareholder preference for ongoing engagement and transparency regarding executive remuneration. The high vote tallies for director elections and auditor ratification suggest confidence in the current leadership and financial oversight of the company.

Key Highlights

  • 1DexCom held its Annual Meeting of Shareholders on May 25, 2011.
  • 2Two directors, Jonathan T. Lord, M.D. and Eric Topol, M.D., were elected to the Board of Directors with substantial shareholder support.
  • 3Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2011, with a significant majority of votes in favor.
  • 4Shareholders approved, on a non-binding advisory basis, the compensation paid to DexCom's named executive officers.
  • 5Shareholders voted in favor of holding an advisory vote on executive compensation every year.
  • 6The company's Board of Directors will implement annual advisory votes on executive compensation based on the shareholder vote.

Frequently Asked Questions

The main items voted on included the election of two directors, the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2011, a non-binding advisory vote on executive compensation, and a non-binding advisory vote on the frequency of future executive compensation votes.

Shareholders approved the compensation paid to DexCom's named executive officers on a non-binding advisory basis. Additionally, shareholders voted in favor of holding these advisory votes annually, a decision that the Board of Directors has committed to implementing.

The directors elected were Jonathan T. Lord, M.D. and Eric Topol, M.D. Both received a significant majority of the votes cast.

While the majority of votes were in favor for most items, there were some 'Withheld' votes for director elections, and a small number of 'Against' and 'Abstaining' votes for the auditor ratification and executive compensation proposals. There were also broker non-votes on several matters, indicating shares held in "street name" where the broker did not receive voting instructions.